Vector Biolabs is a biotechnology company headquartered in Philadelphia, Pennsylvania, focused on high-quality AAV (adeno-associated virus) and adenoviral products. The company provides comprehensive services including custom viral vector production, vector design, cloning, amplification, packaging, purification, and titer determination. It also maintains a catalog of more than 90,000 custom AAV products targeting human, mouse, and rat genomes, serving global customers ranging from biopharmaceutical companies to research institutions. In addition, Vector Biolabs supports the research community with services related to gene expression, gene editing, and gene silencing.
Vicbio Biotechnology Co., Ltd. provides the full range of Vectorbiolabs products.
⇨ Inquire or Order immediately ⇦
Vector Biolabs offers custom AAV vector production tailored to specific research or therapeutic requirements, helping customers develop solutions for a wide range of gene delivery applications.
The company provides a range of control products for AAV gene therapy studies, supporting experimental accuracy, consistency, and reliability.
Vector Biolabs offers adenoviral vector construction and amplification services to support viral vector development and related research workflows.
The company provides shRNA screening and validation services, along with a related product catalog, to support gene silencing research and functional genomics studies.
AAV vectors offer several important advantages for gene therapy applications, including low immunogenicity, stable non-integrating gene delivery, scalable manufacturing from research to clinical supply, and broad utility for targeting organs such as the brain, liver, and retina.
| Product Name | Cat. # | AAV Serotype | AAV ITR | Promoter | Reporter | Storage Buffer | Titer | Volume (µL) |
| AAV1-LacZ | 7001 | AAV1 | AAV2 | CMV (ubiquitous) | LacZ | PBS/5% Glycerol | 1x10^13 GC/ml | 20 |
| AAV1-GFP | 7002 | AAV1 | AAV2 | CMV (ubiquitous) | eGFP | PBS/5% Glycerol | 1x10^13 GC/ml | 20 |
| AAV2-LacZ | 7003 | AAV2 | AAV2 | CMV (ubiquitous) | LacZ | PBS/5% Glycerol | 1x10^13 GC/ml | 20 |
| AAV2-GFP | 7004 | AAV2 | AAV2 | CMV (ubiquitous) | eGFP | PBS/5% Glycerol | 1x10^13 GC/ml | 20 |
| AAV5-LacZ | 7005 | AAV5 | AAV2 | CMV (ubiquitous) | LacZ | PBS/5% Glycerol | 1x10^13 GC/ml | 20 |
| AAV5-GFP | 7006 | AAV5 | AAV2 | CMV (ubiquitous) | eGFP | PBS/5% Glycerol | 1x10^13 GC/ml | 20 |
| AAV9-GFP | 7007 | AAV9 | AAV2 | CMV (ubiquitous) | eGFP | PBS/5% Glycerol | 1x10^13 GC/ml | 20 |
| AAV6-GFP | 7008 | AAV6 | AAV2 | CMV (ubiquitous) | eGFP | PBS/5% Glycerol | 1x10^13 GC/ml | 20 |
| AAV1-Cre | 7010 | AAV1 | AAV2 | CMV (ubiquitous) | - | PBS/5% Glycerol | 1x10^13 GC/ml | 20 |
| AAV2-Cre | 7011 | AAV2 | AAV2 | CMV (ubiquitous) | - | PBS/5% Glycerol | 1x10^13 GC/ml | 20 |
| AAV5-Cre | 7012 | AAV5 | AAV2 | CMV (ubiquitous) | - | PBS/5% Glycerol | 1x10^13 GC/ml | 20 |
| AAV6-Cre | 7013 | AAV6 | AAV2 | CMV (ubiquitous) | - | PBS/5% Glycerol | 1x10^13 GC/ml | 20 |
